Aurobindo Pharma Gets Tentative US Approval for HIV Treatment
Thursday, 12 March 2009
India's Aurobindo Pharma Ltd. (524804.BY) said Thursday it has received U.S. Food and Drug Administration's tentative approval to sell generic lopinavir/ritonavir tablets.
The company said the approval is for lopinavir/ritonavir tablets in 100/25- milligram and 200/50-mg doses. The drug is a generic equivalent of Abbott Laboratories' (ABT) Kaletra tablets.
The tablets are indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection in adults and children above the age of two years, the company said in a statement.
Add this page to your favorite Social Bookmarking websites
India's Aurobindo Pharma Ltd. (524804.BY) said Thursday it has received U.S. Food and Drug Administration's tentative approval to sell generic lopinavir/ritonavir tablets.
